Apollo Care, LLC
Apollo Care, LLC appears in FDA public data with 34 recalls, 0 510(k) clearances, 4 FDA inspections, and 2 compliance actions on record. Its most recent recall (D-0753-2026, Class II) was initiated on July 29, 2026.
Summary
- Total Recalls
- 34
- 510(k) Clearances
- 0
- Inspections
- 4
- Compliance Actions
- 2
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0753-2026 | Class II | SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For S | July 29, 2026 |
| D-0747-2026 | Class II | SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Onl | July 29, 2026 |
| D-0749-2026 | Class II | SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection | July 29, 2026 |
| D-0755-2026 | Class II | SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Su | July 29, 2026 |
| D-0751-2026 | Class II | SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, | July 29, 2026 |
| D-0750-2026 | Class II | SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Onl | July 29, 2026 |
| D-0748-2026 | Class II | SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection | July 29, 2026 |
| D-0756-2026 | Class II | SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcut | July 29, 2026 |
| D-0752-2026 | Class II | SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Onl | July 29, 2026 |
| D-0757-2026 | Class II | SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcut | July 29, 2026 |
| D-0754-2026 | Class II | SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcuta | July 29, 2026 |
| D-0409-2025 | Class II | FentaNYL 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (0.1%) added to 250 mL, 0.9% Sodium Chloride Inj | April 15, 2025 |
| D-0646-2023 | Class II | FentaNYL 500 mcg (2mcg/mL) and Ropivacaine HCL 250 mg (0.1%) added to 250 mL 0.9% Sodium Chloride In | May 2, 2023 |
| D-0639-2023 | Class II | VANComycin 1.25g added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apollo Care, LLC, 3801 | May 2, 2023 |
| D-0636-2023 | Class II | VANComycin 1.5g added to 500 mL of 0.9% Sodium Chloride Injection, Rx only, Apollo Care, LLC, 3801 M | May 2, 2023 |
| D-0647-2023 | Class II | VANComycin 1.5g added to 250 mL of 0.9% Sodium Chloride Injection, Rx only, Apollo Care, LLC, 3801 M | May 2, 2023 |
| D-0641-2023 | Class II | VANComycin 1.75 g added to 500 mL of 0.9% Sodium Chloride Injection, Rx Only, Apollo Care, LLC, 3801 | May 2, 2023 |
| D-0644-2023 | Class II | Norepinephrine 4 mg added to 250 mL of 5% Dextrose Injection, Rx Only, Apollo Care, LLC, 3801 Mojave | May 2, 2023 |
| D-0643-2023 | Class II | VANComycin 2.5 g added to 500 mL of 0.9% Sodium Chloride Injection, Rx Only, Apollo Care, LLC, 3801 | May 2, 2023 |
| D-0642-2023 | Class II | VANComycin 2g added to 500 mL of 0.9% Sodium Chloride Injection, Rx Only. Apollo Care, LLC, 3801 Mo | May 2, 2023 |